Soligenix more than doubles as traders react to Ebola-outbreak vaccine-platform update

By: Quiver PriceTracker

Posted: 22 hours ago / May 27, 2026 5:36 p.m. UTC

SNGX

Soligenix, Inc. (SNGX) is up 102.7% today. Here is some analysis on what might have caused this price movement.

Analysis: The move appears tied to a company update highlighting the potential applicability of Soligenix’s thermostable filovirus vaccine platform to the Bundibugyo virus, linked to an Ebola outbreak. With SNGX a thinly traded micro-cap, the news likely triggered momentum buying and possible short-covering as volume surged.

Details:

Soligenix issued a May 26, 2026 press release describing how prior thermostability, immunogenicity, and efficacy work on related filovirus vaccines could provide a rapid starting point for Bundibugyo vaccine development.

The company said its filovirus vaccine work has been developed in collaboration with the University of Hawaiʻi at Mānoa, and discussed a single-vial, reconstituted protein subunit approach designed to ease storage and distribution logistics.

The release referenced the Bundibugyo outbreak context and described the public-health urgency as a key reason new vaccine formulation efforts may be needed.

Trading activity spiked sharply versus recent norms, with share volume vastly above typical 30-day averages, consistent with a momentum-driven breakout in a low-float name.

Sources:

Soligenix Investor Relations, ChartExchange

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

EARLY ACCESS

Receive SNGX Data Alerts

Real-time alerts on filings, insider trades, and market signals — before everyone else.

Get Alerts →

$SNGX Hedge Fund Activity

We have seen 6 institutional investors add shares of $SNGX stock to their portfolio, and 18 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

ARMISTICE CAPITAL, LLC removed 708,000 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $948,720
DRW SECURITIES, LLC removed 124,801 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $147,265
TWO SIGMA INVESTMENTS, LP removed 87,646 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $117,445
SABBY MANAGEMENT, LLC removed 81,000 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $108,540
RENAISSANCE TECHNOLOGIES LLC removed 72,900 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $97,686
HRT FINANCIAL LP removed 54,669 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $73,256
BANCO BTG PACTUAL S.A. removed 46,372 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $62,138

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.